FAS REREGISTERED THE FIRST PRICE FOR A REFERENCE MEDICINE

24-01-2020 | 18:49

FAS forwarded a decision on approving the maximum ex-work price for a Hungarian-made medicine - bromocriptine - to the Ministry of Healthcare of the Russian Federation

 

Although the procedure for mandatory re-registration of the maximum ex-works prices for vital and essential medicinal medicine (VED) [1] came into force relatively recently – on 17 December 2019, the antimonopoly authority has already launched robust efforts to execute the instructions of the Government of Russia.

 

“FAS has successfully agreed upon the first price for a reference medicine - bromocriptine, which is listed as a vital and essential drug. The decision оn approval was published on the official web-site of the Antimonopoly Service and is forwarded to the Ministry of Healthcare of the Russian Federation. FAS expects that all manufacturers on the Russian pharmaceutical market should be actively involved in reviewing prices for medicine, which will allow us to adjust them in accord with the prices on medicine in the reference countries”, says Timophei Nizhegorodtsev, Head of FAS Department for Control over Social Sphere and Trade.

 

Manufacturers must file applications for mandatory registration of prices for original (reference) medicines to the Ministry of Healthcare of the Russian Federation by 18 February 2020. Reviewed ceiling ex-works prices for medicine come into effect five months after a relevant order of the Russian Ministry of Healthcare is issued.

 

Reviewing prices for medicines listed as vital and essential medicine must be completed by the end of 2020.

 

Background:

 

[1] № 1683 Decree of the Government of the Russian Federation of 16.12.2019.



Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Coordination Committee on antimonopoly policy BRICS Working Groups for the research of competition issues in socially important markets Cooperation within the BRICS BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide